跳至主要内容
临床试验/TCTR20200306004
TCTR20200306004尚未招募3 期

The Effect of Early Initiation of SGLT2 Inhibitors in Reducing Heart Failure Events After MI

Faculty of Medicine, Chiang Mai University0 个研究点目标入组 476 人开始时间: 2020年3月6日最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
476

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
35 Years 至 0 N/A (No limit)(—)
性别
All

入选标准

  • 1.Male or female patients ≥ 35 years of age
  • 2.Diagnosis of ACS based on the 4th universal definition between 24 hours and 10 days before treatment allocation
  • 3.LVEF ≤ 40% after index MI or
  • 4.LVEF > 40% with symptomatic heart failure requiring iv diuretic or elevate natriuretic peptides NT-proBNP ≥ 600 pg/ml, if atrial fibrillation or flutter ≥ 900 pg/ml with Killip class II to IV
  • 5.Hemodynamic stable defined as SBP ≥ 100 mmHg at initiation of treatment, no symptomatic hypotension
  • 6.No increase in intravenous diuretics
  • 7.No intravenous inotrope or intravenous vasodilators
  • 8.Received revascularization to IRA with PCI

排除标准

  • 1.Cardiogenic shock within last 24 hours prior to the screening
  • 2.Planned CABG or cardiac surgery within next 3 months
  • 3.Symptomatic hypotension at screening
  • 4.Stroke or TIA 1 month prior to the screening
  • 5.History of bladder cancer or history of radiation therapy to the lower abdomen or pelvis at any time
  • 6.Impaired renal function, defined as GFR < 30 ml/min (MDRD formula) at screening
  • 7.Diagnosis of Myocardial Infarction with Nonobstructive Coronary Arteries (MINOCA)
  • 8.Life expectancy < 1 year
  • 9. Prior diagnosis of heart failure

研究者

发起方
Faculty of Medicine&#44; Chiang Mai University

相似试验

The Effect of Early Initiation of SGLT2 Inhibitors... | 临床试验